2015 ACR/ARHP Annual Meeting

November 6-11, 2015. San Francisco, CA.

View by Number View by Title View Sessions

View by Date

Tuesday, November 10, 2015

9:00AM-11:00AM: Abstract Number: 2406

The 2011 Fibromyalgia (FM) Criteria Are Helpful in Identifying Central Sensitization in Knee Osteoarthritis

Osteoarthritis - Clinical Aspects Poster II: Biomarkers, Biomechanics and Health Services Research

9:00AM-11:00AM: Abstract Number: 2290

The 2011 Fibromyalgia (FM) Survey Criteria Are a Surrogate Measure of Pain Centralization

Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes Poster II

9:00AM-11:00AM: Abstract Number: 2857

The 8-Year Retention Rate of the First TNF-Inhibitor in the Treatment of Spondyloarthropathies: Real-Life Data from Three Local Registries

Spondylarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment Poster III: Therapy

9:00AM-11:00AM: Abstract Number: 2176

The Ability of Recombinant Domain I of Beta-2-Glycoprotein I to Inhibit Lupus Anticoagulant Effect of IgG from Patients with APS Is Enhanced By Pegylation

Antiphospholipid Syndrome: Basic Science

9:00AM-11:00AM: Abstract Number: 2396

The Absence of Symptom in Subjects with Advanced Knee OA

Osteoarthritis - Clinical Aspects Poster II: Biomarkers, Biomechanics and Health Services Research

9:00AM-11:00AM: Abstract Number: 3021

The Adaptor Protein Crkii Regulates Rap1 Activation in the Immunological Synapse

T cell Biology and Targets in Autoimmune Disease Poster II

9:00AM-11:00AM: Abstract Number: 2366

The Anti-MDA5 Autoantibody Phenotype: Defining Clinical, Biochemical and Radiological Features Suggestive of Anti-MDA5-Associated Rapidly Progressive Interstitial Lung Disease

Muscle Biology, Myositis and Myopathies Poster II: Autoantibodies and Treatments in Inflammatory Myopathies

9:00AM-11:00AM: Abstract Number: 3060

The Assessment of Disease Activity in Takayasu Arteritis; Six Years Experience from a Single Center

Vasculitis Poster III

9:00AM-11:00AM: Abstract Number: 3036

The Association Between Behcet’s Disease, Myelodysplastic Syndrome and Trisomy 8

Vasculitis Poster III

9:00AM-11:00AM: Abstract Number: 2479

The Association Between Social Networks, Disease Activity, and Pain in Rheumatoid Arthritis

Psychology/Social Sciences (ARHP)

9:00AM-11:00AM: Abstract Number: 2276

The Association of Knee Pain and Knee Osteoarthritis with Incident Widespread Pain: The Multicenter Osteoarthritis (MOST) Study

Epidemiology and Public Health Poster (ARHP)

9:00AM-11:00AM: Abstract Number: 2275

The Burden of Axial Spondyloarthritis: A Comparison of the Radiographic and Non-Radiographic Groups

Epidemiology and Public Health Poster (ARHP)

9:00AM-11:00AM: Abstract Number: 3019

The CD4+CD52low T Cell Contributes to Disease Activity and Autoantybody Production in Systemic Lupus Erythematosus

T cell Biology and Targets in Autoimmune Disease Poster II

9:00AM-11:00AM: Abstract Number: 2371

The Clinical Features of Recurrent Interstitial Lung Disease in Dermatomyositis Patients with Anti- Melanoma Differentiation-Associated Gene 5 Antibody

Muscle Biology, Myositis and Myopathies Poster II: Autoantibodies and Treatments in Inflammatory Myopathies

9:00AM-11:00AM: Abstract Number: 2384

The Comparative Efficacy of Dry Needling, Kinesio Taping and Physical Therapy in Patients with Myofascial Pain Syndrome

Orthopedics, Low Back Pain and Rehabilitation Poster (ARHP): Rehabilitation Sciences

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].